|
|
July 31, 2008 |
|
|
Eastman Kodak(EK) still not photogenic |
|
|
|
Once again Eastman Kodak (EK) has disappointed investors again as it posted 2nd quarter profits that trailed analysts estimates. The company says in the first half of this year due to the unprecedented increase in commodity prices, cost reductions in Entertainment imaging they were not able to keep up with revenue declines for the period. Going forward, however, they will be aggressively managing the cost side of the equation in FPEG including the adjustment of cost structure in ways that will enable a sustainable, profitable business model...
However with a FusionIQ score that is still low, a 31 (Master Technical Score) – It appears EK shares will be dead money for a while.
Did you also know that Fusion offers money management services? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 30, 2008 |
|
|
Breakouts |
|
|
|
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 30, 2008 |
|
|
Short Squeezes |
|
|
|
FusionIQ runs powerful trading screens to help investors isolate candidates that may offer short-term price surges. Today we share our proprietary short squeeze screen that FusionIQ subscribers have access to everyday.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 30, 2008 |
|
|
Volume Buys |
|
|
|
FusionIQ users can create powerful trading screens everyday to help isolate new trading candidates. Today we share a sample screen we created which looks for stocks that have new FusionIQ BUY signals and are also trading up on above average volume.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 29, 2008 |
|
|
Former leadership groups loose their luster |
|
|
|
As the attached table shows the prior leadership areas of the market, Energy, Oil and Commodity related have lost their luster of late recording the biggest one month drops in FusionIQ technical scores. This loss of the last leadership areas of the market also suggest there is more corrective activity coming.
|
|
|
|
July 29, 2008 |
|
|
Too Many Low Ranked FusionIQ Scores for serious rally |
|
|
|
As seen in the attached bar chart. FusionIQ tracks the aggregate scores by decile class clusters to see how strong or weak the tone of the market is. Currently as seen by the blue bar there are close to 70 % of stocks within the FusionIQ Universe ranked below 40. This high level of low ranking suggest that we are likley to still have lower lows to come. At some point this indicator will act like an oscillator and suggest we are deeply oversold, however we don't appear to be there just yet.
|
|
|
|
July 29, 2008 |
|
|
ACE Ltd (ACE) - Timely Sell Signal |
|
|
|
Knowing when to sell a stock is probably more important than buying a stock. As seen in the attached blog post on Ace Ltd. (ACE - FusionIQ Technical Rank - 21 out of a possible 100) using FusionIQ's unbiased timing SELL signals can help remove the emotion from the selling discipline and help one make better decisions.
|
|
|
|
July 28, 2008 |
|
|
OLIN CORP (OLN) new short squeeze and nice upside price target |
|
|
|
Olin Corp (OLN -FusionIQ Technical Score 99 out of a possible 100) said Friday that its profit jumped 62 percent in the second quarter to $35.5 million, or 47 cents a share, from $21.9 million, or 29 cents a share, a year earlier, and cited the acquisition of Pioneer. Its sales for the second quarter were $428.3 million, up 61 percent from $266.2 million in the second quarter of 2007.
"Chlor Alkali earnings improved 27 percent compared with the second quarter of 2007, which reflects the contributions and synergies of the Pioneer acquisition and improved pricing," said Joseph Rupp, chairman, president and chief executive, in a statement.
With close to 12.00 % of its float short and a point and figure target of $ 37.50 there is still ample upside for investors.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 28, 2008 |
|
|
Data I/O Corp. (DAIO) revenues shoot up 39 percent |
|
|
|
Data I/O Corp ((DAIO - FusionIQ Technical Score 98 (out of 100)) said second-quarter revenues increased to $8 million from $5.8 million a year earlier and net income rose to $1.2 million, or 13 cents per share, from a loss of $1.1 million, or a loss of 13 cents per share in 2007. With a point and figure target of $ 13.75 after solid fundamental sales performance and an increased backlog, DAIO offers solid upside potential.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 25, 2008 |
|
|
FusionIQ Custom Screen - New Volume BUYS |
|
|
|
FusionIQ users can create powerful trading screens everyday to help isolate new trading candidates. Today we share a sample screen we created which looks for stocks that have new FusionIQ BUY signals and are also trading up on above average volume.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 25, 2008 |
|
|
New Short Squeezes |
|
|
|
FusionIQ runs powerful trading screens to help investors isolate candidates that may offer short-term price surges. Today we share our proprietary short squeeze screen that FusionIQ subscribers have access to everyday.
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at www.fusioninvest.com/riskprofiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 24, 2008 |
|
|
Sybase Inc. (SY) - Raising Target to $ 40.00 |
|
|
|
Back on January 29th 2008 we published an in-depth research report on SY shares. Today, based on the technical strength and the strong quarter; Database License Revenues up 38 % year over year, Messaging Revenue up 41 % year over year. Additionally Management raised Full-Year Revenue, Earnings and Cash Flow Guidance, we are now raising our target to $ 40.00
To Get Access to more in depth research reports subscribe today at www.fusioniqrank.com/signup.php
Did you also know that Fusion offers money management services ? Take our complimentary risk profile at Fusion Invest. Risk Profiler or call us toll free at 1-888-661-2022 to set up a call with an advisor.
|
|
|
|
July 24, 2008 |
|
|
Qualcomm Inc. (QCOM) Soaring |
|
|
|
Back on May 27th 2008 we published a full research report on Qualcomm Inc. (QCOM) shares to FusionIQ subscribers. Today QCOM shares are soaring as Qualcomm and Nokia Corp. (NOK) ended a long-running patent dispute, agreeing to license each other's technology in a potential boon for the wireless-equipment industry.
To see the full QCOM research report as well as many other subscribe today at www.fusioniqrank.com.subscribe.php
|
|
|
|
July 24, 2008 |
|
|
Western Union Company (WU) breaking out |
|
|
|
Yesterday for FusionIQ subscribers we published a full research report on Western Union Company (WU) highlighting how it broke out of a nice base and above a resistance zone in the $ 24.00 to $ 26.00 range on above average volume. Western Union shares which rank a 97 out of a possible 100 in our FusionIQTM quantitative ranking system recently had a strong quarter besting estimates by 0.02 cents. Additionally the company guided FY08 EPS above consensus and reaffirmed revenue growth targets in the 9.00 % to 11.00 % range.
To get the full research report subscribe today at www.fusioniqrank.com/signup.php
|
|
|
|
July 24, 2008 |
|
|
Biotechs/Therapeutics still breaking out |
|
|
|
Lately the biotech/gene and therapeutics issues have been all trading up on above average volume as money rotates into the group for the first time in a while. This area looks to be establishing itself as an emerging leadership area. Today two new issues, ILMN and NABI pop up on the FusionIQ Short Squeeze screen. Both have sizeable float adjusted short interests (24 % and 11 % respectively) and higher point and figure price targets ($ 111 and $ 8.75 respectively).
Given the rotation to biotech these two names look to offer solid near-term return potential.
|
|
|
|
July 23, 2008 |
|
|
Sneak Peak at FusionIQ 2.0 |
|
|
|
In Late August or early September we will be rolling out version 2.0 of FusionIQ. This upgrade will have enhanced charting capabilities, customizable home page layouts and tons of new trading screens. Below are a few sneak previews of some of the new trading screens that users will be able to choose in their homepage layouts:
Hot and Cold lists – Stocks that are making continuous new highs and lows.
High and Low ranked ETF’s – A daily listing of the best and worst ETF’s
|
|
|
|
July 23, 2008 |
|
|
FusionIQ Above Average Volume Buys |
|
|
|
Please find attached our custom screen that shows stocks that traded up on abnormal volume and also scored new FusionIQ timing buys signals.
|
|
|
|
July 23, 2008 |
|
|
Transports and Biotech dominate the short squeeze list |
|
|
|
As seen in the attached table of new FusionIQ short squeezes, transportation stocks and biotechnology stocks which have been leaders over the last few weeks, dominate the short squeeze activity. This concentration in certain groups suggest there are aggressive buyers moving into these sectors.
|
|
|
|
July 21, 2008 |
|
|
Graham Corp. (GHM) - Relative Strength Leader |
|
|
|
Graham Corp. (GHM) which designs and builds vacuum and heat transfer equipment for process industries around the world, scored a breakout to new highs yesterday amidst the mess that is the market of late. Stocks that act strong in weak tapes tend to suggest bullish underlying fundamentals. With a point and figure target of $ 100.00 there is still solid trading upside, particularly if GHM shares are acquired on a modest pullback.
|
|
|
|
July 21, 2008 |
|
|
Bank of America beats estimates |
|
|
|
Bank of America (BAC) recorded a profit that fell 41.0%, to 72 cents a share, but still bested the consensus estimate of 53 cents a share. BofA gained $2.71, or 9.9%, to $30.20, to help lead the Dow 29 points, or 0.3%, higher, to 11,525. However, with such a low FusionIQ score of 9 don’t expect BAC to be off to the races anytime soon. It is likely BAC will have to develop a long trading range before it can make any sustainable upside advances.
|
|
|
|
July 18, 2008 |
|
|
FusionIQ Custom Screen - Above Average Volume BUYS |
|
|
|
FusionIQ has powerful custom screening capabilities allowing investors to screen on technical metrics, fundamental metrics or both. Attached is a custom screen we run from time to time to time that shows stocks trading up on above average volume, a sign of strong institutional interest. Writing custom screens is just one of the many features FusionIQ offers.
|
|
|
|
July 18, 2008 |
|
|
Rent A Center (RCII) - In tought times people rent not buy |
|
|
|
Rent a Center (RCII - FusionIQ Master Technical Rank 78) scored a high volume breakout yesterday as shares traded up on over two times its' 21-day average volume. With a slowing economy RCII should pick up increased business as people look to avoid large outlays and rent giving them more manageable monthly rental payments. With a point and figure target of $ 35.00 RCII offer tremendous upside.
As long as shares stay above $ 20.00 the long term technical outlook will remain bullish.
|
|
|
|
July 17, 2008 |
|
|
Awaiting Google (GOOG) |
|
|
|
Google Inc.'s (GOOG - FusionIQ Master Technical Rank - 53) which reports 2nd quarter earnings after the stock market closes Thursday gives investors another look at how to assess how well the Internet search leader is holding up in a slumping U.S. economy. Here are some of the key issues likely to sway the stock market's reaction.
Though its growth rate has decelerated as revenue has ballooned, Google is still growing at a rapid clip. Revenue rose 42 percent in the first quarter and analysts are projecting an increase in the same range during the latest quarter ended in June, despite the financial turmoil that's hurting scores of other businesses. The extensive reach of Google's search engine outside the United States is one of the biggest reasons why the Mountain View, Calif.-based company is still faring so well. International markets accounted for more than half of Google's revenue for the first time in the first quarter and even more revenues is expected to pour in from outside the United States in the second quarter.
For the record FusionIQ's predicted surprise is predicting a marginal upside surprise.
To see whether your stock is going to beat earnings subscribe today at https://www.fusioniqrank.com/signup.php
|
|
|
|
July 17, 2008 |
|
|
Ebay Inc. (EBAY) plunges |
|
|
|
EBay Inc's (EBAY - FusionIQ Technical Rank - 16) shares fell more than 13 today after its cautious near-term outlook led to downgrades by several Wall Street analysts. EBay's caution reflected concern about a weak U.S. economy and changes it has been making to its auction business. Analysts at Merrill Lynch and Goldman Sachs cut eBay to "Neutral" from "Buy," while Lehman and Jefferies both lowered their price target for the online auction house.
Given its low FusionIQ rating prior to the comments FusionIQ users would not have been invested in EBAY as stocks ranked below 60 are considered bad investment opportunities.
|
|
|
|
July 16, 2008 |
|
|
FusionIQ Short Squeezes for July 16th 2008 |
|
|
|
Excessive short interest can be a powerful liquidity catalysts in the short and intermediate run as its creates a double buying effect as both natural buyers as well as shorts stampede into a stock simultaneously. The attached table shows a list of stocks from the FusionIQ software platform that meet our proprietary short squeeze criteria and may offer good short-term upside trading potential over the coming days and weeks.
|
|
|
|
July 16, 2008 |
|
|
Intel Beats Q2 Sales, Gross Margin Light however Guidance Solid |
|
|
|
Intel Corp. (INTC - FusionIQ Master Technical Rank 11) blew away Wall Street revenue and EPS expectations for Q2, however gross margins were a bit lower than forecasted. Why? Greater demand for cheap laptops, which include cheaper chips. The company did however give solid guidance for Q3. Intel CEO Paul Otellini said in a statement, "As we enter the second half, demand remains strong for our microprocessor and chipset products in all segments and all parts of the globe."
While this news is seemingly bullish, with a FusionIQ Master technical rank of only 11, INTC shares are likely to be viewed as nothing more than a trading BUY as opposed to a long term secular BUY at this point.
|
|
|
|
July 16, 2008 |
|
|
iShares Nasdaq Biotechnology Index Fund (IBB) - scores new FusionIQ BUY |
|
|
|
iShares NASDAQ Biotechnology Index Fund (IBB - FusionIQ Technical Rank 74) - an exchange-traded that seeks investment results that correspond to the performance of the NASDAQ Biotechnology Index (NBI) scored a new FusionIQ BUY signal yesterday. The across the board strength in biotech the last few days shows this is an emerging area of new leadership.
Point and Figure target for IBB is 98.00.
|
|
|
|
July 16, 2008 |
|
|
Cephalon Inc. (CEPH) - scores hat trick, short squeeze, breakout and new BUY on positive Treanda data |
|
|
|
Biotechnology company Cephalon Inc. (CEPH - FusionIQ Technical Rank 71) said Tuesday its leukemia drug Treanda, in combination with Genentech Inc.'s (DNA -FusionIQ Technical Rank 71) Rituxan, prompted a response in non-Hodgkin's lymphoma patients during a midstage study. The study results were published Tuesday in the Journal of Clinical Oncology and were part of a series of study data filed with the Food and Drug Administration in December. Cephalon has asked the regulatory agency to approve Treanda as a treatment for non-Hodgkin's lymphoma, a type of cancer that starts in a person's lymph system. Rituxan is already approved as a non-Hodgkin's lymphoma and rheumatoid arthritis treatment.
In the Phase II clinical trial, 92 percent of patients with relapsed forms of the cancer responded to the combination therapy. The study involved 66 patients and was one of three studies Cephalon filed with the FDA for the proposed use. The remaining two studies focused on Treanda as a stand-alone treatment for non-Hodgkin's lymphoma.
With a FusionIQ new short squeeze, new timing BUY and breakout along with a point and figure target of $ 83.00 - CEPH shares offer good return potential.
|
|
|
|
July 15, 2008 |
|
|
Revisiting an earlier post - Washington Mutual WAMU How low can you go ? |
|
|
|
Back on June 4th we highlighted WM (see original post below) which had an abysmal FusionIQ score of just 9 (out of a possible 100). Since our post WM has fallen from just under 9.00 to below 4.00 – this is just another example of how FusionIQ with its powerful ranking metrics add value to investors as a risk management tool.
To Subscribe today click here https://www.fusioniqrank.com/signup.php
June 4, 2008
Washington Mutual Inc. (WM) - WAMU how low can you go ?
Washington Mutual Inc. ((WM) “ FusionIQ Master Technical Score ” 9) shares have been like most financials over the last several months, utterly obliterated. However just when many people thought the financials were bottoming now many, such as WM, are making new 52 week lows. The moral of the story is it is hard to catch a falling knife so do not try, unless of course you worked in the circus in a previous life !!
We still remain negative on the financials across the board so do not be seduced by the fact they appear cheap.
|
|
|
|
July 14, 2008 |
|
|
First Cash Financial Services, Inc (FCFS) - Paw Shop Scores a new FusionIQ Short Squeeze |
|
|
|
First Cash Financial Services, Inc. (FCFS) which operates pawn stores scored a new FusionIQ Short Squeeze on Friday as investors assume business will pick up in a slowing economy. With close to 14.00% of its float short and a point and figure target of $ 34.00 FCFS offers investors a solid upside return potential within the framework of a possibly growing macro theme (ie. companies that benefit from a weakening economy).
|
|
|
|
July 14, 2008 |
|
|
Natus Medical Incorporated (BABY) new FusionIQ Short Squeeze |
|
|
|
Natus Medical Incorporated (BABY - FusionIQ Master Technical Score - 97) a medical device company that develops, manufactures, and markets screening products to identify and monitor common medical disorders that may occur between conception to a baby's first birthday scored a new FusionIQ Short Squeeze on Friday. We love stocks that act strong in a weak tape and BABY shares certainly fit the bill. With close to 13.00% of its float short and a point and figure target of $ 33.50 and a new FusionIQ BUY signal BABY offers excellent long side return potential.
|
|
|
|
July 11, 2008 |
|
|
General Electric Co. (GE) fails to wow investors |
|
|
|
Industrial and financial conglomerate General Electric Co. (GE - FusionIQ Master Score of 26) announced today that its profit fell 6 percent in the second quarter, and that it has agreed to sell its Japanese consumer finance business for $5.4 billion. Fairfield-based GE earned $5.07 billion, or 51 cents per share, compared with a year-earlier profit of $5.38 billion, or 52 cents per share.
Revenue rose to $46.89 billion from $42.38 billion a year earlier. On the basis of continuing operations, GE said it earned $5.39 billion, or 54 cents per share. Thomson Financial says analysts expected the company to report earnings of 54 cents per share on revenue of $45.31 billion.
With a terrible looking chart and a low FusionIQ score of 26 GE still looks like a name to avoid.
|
|
|
|
July 11, 2008 |
|
|
FusionIQ All Cap Value Screen |
|
|
|
Please see below an All Cap Value stock screen created in FusionIQ powerful custom screener. FusionIQ's custom screener allows traditional fundamental screening but also allows the layover of technical indicators to enhance the screens and find more targeted ideas.
|
|
|
|
July 10, 2008 |
|
|
FusionIQ Breakouts for July 10th |
|
|
|
As we mentioned many times on this blog FusionIQ offers powerful short-term trading screens like the FusionIQ high volume breakouts seen in the table below . This
screen looks to highlight stocks trading up on above average volume, typically a sign of strong institutional interest.
|
|
|
|
July 10, 2008 |
|
|
GMX Resources Inc. (GMXR) - New FusionIQ Short Squeeze |
|
|
|
GMX Resources Inc, which has over 22 % of its float short scored a new short-term FusionIQ short squeeze yesterday. This coupled with its FusionIQ 100 master technical rank suggest shares could continue to surge over the coming days.
|
|
|
|
July 9, 2008 |
|
|
Emergent BioSolutions, Inc. (EBS) breakouts |
|
|
|
Emergent BioSolutions, Inc., (EBS) a biopharmaceutical company, that, develops, manufactures, and commercializes immunobiotics in the United States, the United Kingdom, and Vietnam broke out on 2.5x its 21-day average volume. The company operates in two segments, Biodefense and Commercial. The Biodefense segment offers products for use against biological agents that are potential weapons of bioterrorism and biowarfare; and BioThrax, a vaccine for the prevention of anthrax infection.
With new military budgets approved and terrorism a constant threat we believe EBS's point and figure target of 17.50 is very feasible.
|
|
|
|
July 9, 2008 |
|
|
Idenix Pharmaceuticals Inc. (IDIX) scores FusionIQ short squeeze on positive HIV data |
|
|
|
Idenix Pharmaceuticals Inc. (IDIX) which has close to 18 % of its float short and a FusionIQ technical rating of 81, said it has generated positive clinical trial data from a possible new HIV treatment. The Cambridge, Mass.-based company said Thursday that its drug IDX899 showed "potent antiviral activity" in reducing virus levels at several different doses. Idenix said that patients in the early-stage human clinical trial also avoided any serious reactions from the drug and that no patients left the study. The company tested its drug in HIV patients who have had no prior HIV treatments.
With a point and figure target of $ 12.25 IDIX shares offer good upside potential from present levels.
|
|
|
|
July 8, 2008 |
|
|
EZCORP Inc. (EZPW) scores new FusionIQ Breakout |
|
|
|
EZCORP, Inc. (EZPW) which operates pawn shops, scored a new high-ranked FusionIQ breakout yesterday as it surged 8.5 % on 2x its 21-day average volume. This breakout has a bullish point and figure target of $ 22.00 which offers investors ample upside potential.
|
|
|
|
July 8, 2008 |
|
|
NuVasive Inc. (NUVA) scores new FusionIQ short squeeze |
|
|
|
NuVasive, Inc. (NUVA) which designs, develops, and markets products for the surgical treatment of spine disorders scored a new FusionIQ short squeeze yesterday as it broke out yesterday on almost 2x its 21-day average volume. With close to 17.22 % of its float short NUVA has a large short interest, which should provide plenty of liquidity to drive prices higher. NUVA has been one of the few stocks that has bucked the markets recent weakness. This relative strength suggests confidence on the part of institutions.
|
|
|
|
July 7, 2008 |
|
|
General Motors (GM) Down and out, more job cuts coming |
|
|
|
General Motors Corp (NYSE: FusionIQ Master Rank - 12) is planning to cut thousands of white-collar jobs and is considering whether it should sell or stop production of more of its brands, The Wall Street Journal, citing people familiar with the matter said both moves are part of a broader re-evaluation of the company's strategy and of its ability to meet an internal projection of returning to profitability in 2010, the people told the paper. The job cuts are likely to be approved when GM's board of directors meets in early August, the people said. The reductions would be in addition to earlier announced cuts. Management may also present the board with options for raising additional cash, they told the paper. The board may also hear management's latest thoughts on whether GM should trim the number of brands it offers in the United States, the people told the paper. All but the Cadillac and Chevrolet brands, which GM considers core to its business, are undergoing close scrutiny.
Given the aforementioned bad news and its’ low FusionIQ score don’t expect GM to be a winner anytime soon.
|
|
|
|
July 7, 2008 |
|
|
Aerovironment Inc (AVAV) soaring |
|
|
|
Aerovironment Inc. (AVAV) which develops and produces small unmanned aircraft systems is soaring today up over 10.00 %. FusionIQ subscribers received this email on Thursday July 3rd before todays pop. Guess it pays to be a subscriber !!
Anyway the story for AVAV is as follows: The company has beat earnings estimates the last six quarters and the unmanned aircraft systems are expected to receive more and more funding as part of the new defense budget so growth expectations for AVAV are probably too conservative. In fact Defense Secretary Robert Gates recently stated that Unmanned aerial vehicles (UAVs) can give ground commanders instantaneous information about what they’re facing. He also stated I have taken a special interest in UAVs, because they are ideal for many of today's tasks in today’s wars. They give troops the tremendous advantage of seeing full-motion, real-time, streaming video over a target, such as an insurgent planting an IED on a street corner. This language clearly supports he is behind increasing the budget for these strategic surveillance tools.
With a point and figure target of $ 50.50 and insiders controlling close to 40% of the float AVAV looks to offer good upside potential. We would suggest setting a stop loss commensurate with your personal risk tolerance.
|
|
|
|
July 2, 2008 |
|
|
Celgene Corp. (CELG) shares soar on Supergen Inc's (SUPG) FDA stumble |
|
|
|
Celgene Corp. (CELG) shares scored a high volume breakout yesterday trading up on over four times its 21-day average volume as its competitor Supergen Inc. (SUPG) had its Dacogen drug nixed at the FDA. This negative FDA ruling allows Celgene to retain its 71 % market shares in the MDS market with its Revlimid and Vidaza drugs. The point and figure target for CELG is $ 90.00.
|
|
|
|
July 2, 2008 |
|
|
Olin Corp (OLN) - New FusionIQ Short Squeeze |
|
|
|
Olin Corp. (OLN) a manufacturer of chlorine and caustic soda, sodium hydrosulfite, bleach products, copper, copper alloy sheet, strip welded tube, brass rod and stainless strip, scored a high volume FusionIQ Short Squeeze yesterday. With close to 12.00% of its’ float short and a point and figure price target of $ 37.50 there is still good upside profit potential over the intermediate term.
|
|
|
|
July 1, 2008 |
|
|
Three Major Market ETF's all on FusionIQ Sell Signals |
|
|
|
As the charts below show all three of the major ETF’s; the Powershares QQQQ, the SPDR’s and the Dow Diamonds are all on new FusionIQ sell signals. Since these three are proxies for the major market averages, this does not seem to bode well for the bull camp.
|
|
|
|
July 1, 2008 |
|
|
FusionIQ Short Squeezes dominated by Energy |
|
|
|
As seen in the table below four out of the six stocks that meet the FusionIQ Short Squeeze criteria are in the Oil Comp, Exploration
and production group. Even though many say that the group is extended they still continue to show techical strength.
|
|
|
« June 2008 |
Main Index |
Archives
| August 2008 »
|
|
|
|
|
|